Atlas Trials

Preclinical Assessment of an Engineered HMGB1 Protein as a Novel Companion Therapy for Muscular Dystrophies

Clinical trial NCT07745218 · RECRUITING

Trial details

NCT number
NCT07745218
Sponsor
IRCCS San Raffaele
Status
RECRUITING
Study type
OBSERVATIONAL
LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Start date
2026-08-01
Primary completion
2029-07-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.